NAPSA anticorps

N° du produit ABIN2429227

Détail du produit anti-NAPSA anticorps

Antigène: NAPSA (Napsin A Aspartic Peptidase (NAPSA))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NAPSA est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Purification: Affinity purification

Immunogène: Recombinant protein of human NAPSA

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000, IHC 1:50-1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.6 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Conseil sur la manipulation: Avoid freeze / thaw cycles.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur NAPSA

Antigène: NAPSA (Napsin A Aspartic Peptidase (NAPSA))

Autre désignation: NAPSA (NAPSA Produits)

Synonymes: anticorps KAP, anticorps Kdap, anticorps NAP1, anticorps NAPA, anticorps SNAPA, anticorps pronapsin, anticorps kap, anticorps kdap, anticorps nap1, anticorps napa, anticorps napsa, anticorps snapa, anticorps napsin A aspartic peptidase, anticorps napsin A aspartic peptidase L homeolog, anticorps NAPSA, anticorps Napsa, anticorps napsa.L

Sujet: The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.

Poids moléculaire: Calculated MW: 45 kDa

Pathways: Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis